Visirna Therapeutics HK Limited
5 clinical trials · Sponsor
◉ Watch Visirna Therapeutics HK Limited
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of VSA003 in Chinese HoFH Patients (NCT06712771) | Visirna Therapeutics HK Limited | 2024-11-27 |
| A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients (NCT06322628) | Visirna Therapeutics HK Limited | 2024-04-22 |
| A Phase 3 Study of ARO-APOC3 / VSA001 / SAR449124 (Plozasiran) in Chinese Adults With Familial Chylomicronemia Syndrome (NCT05902598) | Visirna Therapeutics HK Limited | 2023-07-10 |
| A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers (NCT05851066) | Visirna Therapeutics HK Limited | 2023-06-01 |
| Study of VSA001 Injection in Chinese Healthy Adult Volunteers (NCT05757596) | Visirna Therapeutics HK Limited | 2023-05-17 |
Track Visirna Therapeutics HK Limited automatically
Every clearance here is in the API, with alerts when new ones post.